Luke Rudmik
Papers
1
Total Citations
46
H-Index
1
About
Dr. Luke Rudmik is a leading otolaryngologist–head and neck surgeon whose research centers on health economics, surgical outcomes, and the optimization of care for patients with head and neck cancers. His most influential work includes a landmark cost-effectiveness analysis comparing transoral robotic surgery (TORS) to intensity-modulated radiotherapy (IMRT) for early-stage oropharyngeal squamous cell carcinoma. This study, which has garnered 46 citations, provided critical evidence for the value of high-volume robotic surgery centers, demonstrating that TORS can be a cost-effective alternative when performed in specialized settings. Dr. Rudmik’s contributions have shaped clinical decision-making by integrating economic modeling with surgical innovation, helping to guide resource allocation and patient counseling. Beyond this, his broader portfolio addresses quality improvement, chronic rhinosinusitis, and evidence-based practice in otolaryngology. Through rigorous methodological work, he has advanced the field’s understanding of how to balance clinical efficacy with financial sustainability. Dr. Rudmik’s research remains essential reading for surgeons, policymakers, and trainees seeking to navigate the complex intersection of surgical technology, cost, and patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1